A detailed history of Harbour Investments, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Harbour Investments, Inc. holds 10,414 shares of VTRS stock, worth $137,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,414
Previous 8,221 26.68%
Holding current value
$137,256
Previous $87,000 37.93%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$10.32 - $12.13 $22,631 - $26,601
2,193 Added 26.68%
10,414 $120,000
Q2 2024

Jul 26, 2024

SELL
$10.05 - $12.02 $4,703 - $5,625
-468 Reduced 5.39%
8,221 $87,000
Q1 2024

Jul 22, 2024

BUY
$11.27 - $13.53 $6,570 - $7,887
583 Added 7.19%
8,689 $103,000
Q4 2023

Feb 16, 2024

BUY
$8.77 - $10.85 $3,411 - $4,220
389 Added 5.04%
8,106 $87,000
Q3 2023

Nov 15, 2023

SELL
$9.59 - $11.35 $1,534 - $1,816
-160 Reduced 2.03%
7,717 $76,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $13,430 - $15,321
-1,489 Reduced 15.9%
7,877 $78,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $14,066 - $18,745
-1,529 Reduced 14.03%
9,366 $90,000
Q4 2022

Feb 15, 2023

SELL
$8.72 - $11.56 $16,297 - $21,605
-1,869 Reduced 14.64%
10,895 $121,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $11,422 - $14,085
-1,148 Reduced 8.25%
12,764 $134,000
Q4 2021

Feb 16, 2022

SELL
$12.09 - $14.68 $98,315 - $119,377
-8,132 Reduced 36.89%
13,912 $188,000
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $53,463 - $61,049
4,035 Added 22.41%
22,044 $299,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $2,879 - $3,585
222 Added 1.25%
18,009 $257,000
Q1 2021

Aug 17, 2021

BUY
$13.59 - $18.54 $231,587 - $315,940
17,041 Added 2284.32%
17,787 $248,000
Q1 2021

May 12, 2021

BUY
$13.59 - $18.54 $10,138 - $13,830
746 New
746 $10,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.